Dow Corning Ramps Up Production In Response To Influenza Outbreak
In response to an urgent need from a pharmaceutical customer developing flu vaccines and anti-viral drugs to battle potential pandemics, Dow Corning is producing an additional 1 million feet of pharmaceutical grade silicone tubing designed for critical fluid transport and filling applications necessary for drug and vaccine production.
“As the only global silicone manufacturer involved in each step of the manufacturing process—from processing the raw materials to producing extruded and molded pharmaceutical grade silicone—Dow Corning is in a unique position to rapidly provide reliable, proven tubing,” said Carol Pudnos, Dow Corning Healthcare Industry director.
Dow Corning has manufactured products used to meet the stringent requirements of ultra-pure fluid handling for vaccine production for nearly 50 years. The company’s silicone tubing and fabricated tubing assemblies are produced with Dow Corning Silastic® BioMedical Grade Elastomers at Dow Corning’s FDA-registered Health Industries Materials Site in Hemlock, Mich.
“Pharmaceutical companies preparing for possible crises face a number of challenges that demand new solutions that help reduce the risk of contamination and improve processing efficiency, often on short notice and in great quantity,” said Pudnos.
Dow Corning is a CP50 company. To view the Dow Corning profile, visit: http://www.chemicalprocessing.com/cp50/2008/dow_corning.html.
To view the entire CP50 list, visit: http://www.chemicalprocessing.com/cp50.